Clinical trial
Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial
NCT00343876 · Intermountain Health Care, Inc., Other · Completed
Key facts
| NCT number | NCT00343876 |
|---|---|
| Title | Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial |
| Official title | A Single Center, Double-Blind, Randomized Trial to Evaluate the Effects of Aspirin 325 mg + Clopidogrel 75 mg v. Aspirin 325 mg + Placebo on Plasma Concentration of C-Reactive Protein: The CATER Trial Protocol |
| Lead sponsor | Intermountain Health Care, Inc., Other |
| Collaborators | Bristol-Myers Squibb Industry Sanofi-Synthelabo |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | aspirin, clopidogrel |
| Enrollment | 100 |
| Start date | Jul 1, 2005 |
| Completion | Nov 1, 2006 |
| First posted | Jun 23, 2006 |
| Last update posted | Aug 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: